The unanticipated role of the glial-associated glucose-6-phosphatase system in brain homeostasis Authors: María José Barahona, Katterine Salazar, Francisco Nualart Published: 2025 ABSTRACT AbstractThe glucose-6-phosphatase (G6Pase) system is a multiprotein complex within the endoplasmic reticulum that enables glucose export during high energy demand. Although traditionally studied in peripheral tissues such as the liver, recent studies highlight its relevance in the central nervous system, particularly in astrocytes and specialized glial cells called tanycytes. This review explores emerging functions of the G6Pase system in cerebral glial cells and its putative role in the regulation of brain bioenergetics and energy balance. In astrocytes, G6Pase expression supports glucose uptake, ATP production, and endoplasmic reticulum Ca2+ accumulation, contributing to cognitive processes and the counterregulatory response to hypoglycemia. In tanycytes, G6Pase is essential for promoting food intake and maintaining body weight. Collectively, these findings emphasize the importance of the G6Pase system in sustaining brain homeostasis.Subject areas: Glycobiology, Cellular physiology, Neuroscience, Specialized functions of cells Main text The G6Pase system During negative energy balance, when glucose levels fall below 80 mg/dL, the body activates counter-regulatory mechanisms to restore normal glycemia.1 In this process, normoglycemia is achieved through the activation of the sympathetic nervous system,2 which exerts a dual effect on the pancreas—inhibiting insulin secretion and stimulating glucagon secretion. This response promotes glycogenolysis in glucose-releasing organs, such as the liver and, to a lesser extent, kidneys.3,4 Under hypoglycemia, hepatic glucose release into the bloodstream is mediated by the glucose-6-phosphatase (G6Pase) system.4,5,6 In this pathway, G6P—the first intermediate of glycolysis and a product of glycogenolysis—enters the lumen of the endoplasmic reticulum (ER) via the G6P transporter (G6PT) protein (Figure 1).5,6 Inside the ER lumen, G6P is hydrolyzed into glucose and inorganic phosphate (Pi) by the enzyme G6Pase (Figure 1).5,6 The free glucose in the ER lumen may possibly be exported extracellularly through a mechanism that has not yet been elucidated, but it could involve glucose transporters (GLUTs) (Figure 1). Therefore, the G6Pase system regulates hepatic glucose release during hypoglycemia, helping maintain blood glucose levels close to 5 mM. The G6Pase system promotes glucose release in hepatocytes During hypoglycemia, G6P, a product of glycogenolysis, enters the ER via G6PT (yellow box). Inside the ER lumen, G6P is hydrolyzed into free glucose and Pi by G6Pase (blue box). Free glucose is then released into the cytosol and subsequently transported to the extracellular space through GLUTs (purple box). G6P, glucose-6-phosphate; G6PT, glucose-6-phosphate transporter; G6Pase, glucose-6-phosphatase; GLUTs, glucose transporters; ER, endoplasmic reticulum; Pi, inorganic phosphate. Created in BioRender. Barahona, M. (2025) https://BioRender.com/62aqxqb. For several years, the G6Pase system was believed to be exclusively expressed in peripheral tissues that release glucose during hypoglycemia, such as the liver and kidneys.6,7 However, recent studies have strongly suggested that the G6Pase system is also present in the central nervous system (CNS), where it plays a crucial role in regulating brain energy homeostasis.8,9,10 To better understand how the cerebral G6Pase system functions, an in-depth examination of its kinetic properties, isoforms, and expression within the CNS is necessary. Kinetic properties and brain expression of the G6Pase system Before exploring the distribution of the G6Pase system in the brain and its role in energy balance regulation, it is crucial to examine its kinetic properties. The intracellular concentration of G6P can reach approximately 2 mM. However, G6Pase in the liver exhibits a higher Km value (at 3 mM) than its substrate.4,11 Studies on intact microsomes have shown that G6Pase specifically catalyzes the hydrolysis of G6P.4,12 However, when microsomes are treated with detergents, G6Pase can also hydrolyze alternative substrates such as mannose-6-phosphate and glucosamine-6-phosphate.13 In humans, three enzymes hydrolyze G6P, which are encoded by G6pc1, G6pc2, and G6pc3.11 First, the G6pc1 isoform, also known as G6Pase-α, consists of 357 amino acids11,14 and is predominantly expressed in the liver, renal cortex, intestinal mucosa, and pancreatic β-cells in both humans and rodents (Figure 2A).15,16 In the liver, the catalytic subunit of G6Pase-α hydrolyzes G6P to generate glucose and Pi. Second, the G6pc2 isoform, also known as islet-specific G6PC-related protein, is exclusively found in the pancreatic β-cells of humans and mice (Figure 2B)11,17,18 and plays a role in regulating glucose levels during fasting.19,20 Third, the G6pc3 isoform, also known as G6Pase-β, is composed of 346 amino acids21,22 and is ubiquitously expressed across tissues.21,23 The G6pc1, G6pc2, and G6pc3 isoforms share a similar membrane topology, each containing nine transmembrane domains in the ER.24,25,26,27 They also exhibit similar active sites and comparable Km values for G6P hydrolysis.22,28 Notably, G6Pase-β is the only G6Pase isoform expressed in the brain. As G6PT is ubiquitously expressed29 and functionally coupled to G6Pase-β,22 it is plausible that nonhepatic tissues, such as the brain, can store and release glucose via the ER–G6Pase system. In this context, the G6Pase system has been reported to be expressed in the U-87 glioblastoma cell line,30 mouse astrocytes,31 human fetal astrocytes,9 and mouse hypothalamic tanycytes (Figure 2C).8 However, the expression of the G6Pase system has not been reported in other brain cells such as neurons or oligodendrocytes.32,33 G6Pase distribution in humans and mice (A) G6pc1 is expressed in peripheral tissues, including the liver, renal cortex, intestinal mucosa, and pancreatic beta cells. (B) G6pc2 expression is restricted to pancreatic beta cells. (C) G6pc3 is detected in the CNS, predominantly in human astrocytes and mouse tanycytes. Created in BioRender. Barahona, M. (2025) https://BioRender.com/hbx9bzq. This leads to a compelling question: what role does the G6Pase system play in astrocytes and hypothalamic tanycytes, and how does it contribute to the regulation of cerebral homeostasis? Initial insights into this question emerged in 2018 and are discussed below. Astrocytes associated-G6Pase system Astrocytes are a type of glial cell that play an important role in homeostasis and neuronal function in the brain.34 Using an antibody directed against the catalytic subunit of G6Pase, it has been reported that this enzyme is in some human GFAP+ astrocytes but not in all astrocytes.32 Moreover, it has been determined that G6Pase is localized in the cell body, processes, and terminal feet of astrocytes that surround blood vessels but not in radial glia positive for GFAP.32 Interestingly, through kinetic analysis, it was determined that astrocytic G6Pase has a Km at least four times higher than the calculated Km for peripherally expressed G6Pase. Thus, the calculated Km for G6Pase in intact astrocytic microsomes is 27.7 ± 6.9 mM when G6P is used as the substrate.35 In addition to the above, kinetic studies conducted on rat brain microsomes have determined that the Km of G6Pase is close to 15 mM and that its activity in the hydrolysis of G6P decreases as the animal ages.35,36 As described in the beginning of this section, the G6Pase system is predominantly expressed in astrocytes that extend their end feet toward blood vessels, also known as perivascular astrocytes.32 These glial cells, integral to the blood-brain barrier (BBB), play numerous physiological roles, including neuronal support.37 Their strategic positioning in the brain enables simultaneous contact with both blood vessels and neurons in the brain parenchyma (Figure 3A).37 Through their perivascular feet, which contact the blood vessels, perivascular astrocytes efficiently uptake glucose due to the high expression of facilitative GLUT1 (Figure 3A).38 Simultaneously, they maintain close interactions with parenchymal neurons, facilitating communication of the body’s metabolic state. G6Pase system in perivascular astrocytes (A) Glucose is taken up by astrocytes via GLUT1 in the perivascular foot. (B) Intracellular glucose is phosphorylated to G6P via HK, which is then transported into the ER lumen through G6PT. (C) In the ER, G6P is hydrolyzed by G6Pase-β. (D) Free glucose stored in the ER is transferred from the perivascular foot to the perineuronal foot of astrocytes. Here, glucose can be metabolized into lactate or ATP, both of which may be released into the synaptic space. Perivascular astrocytes simultaneously interact with blood capillaries and neurons. GLUT1, glucose transporter 1; G6P, glucose-6-phosphate; HK, hexokinase; G6PT, glucose-6-phosphate transporter; G6Pase-β, glucose-6-phosphatase-β; ER, endoplasmic reticulum. Created in BioRender. Barahona, M. (2026) https://BioRender.com/xrto4cj. In 2018, it was first proposed and demonstrated that perivascular astrocytes utilize the G6Pase system to import glucose into the ER, creating intracellular glucose reservoirs.9 Through advanced techniques in human fetal astrocyte cultures, Müller et al. suggested that the astrocytic ER serves as a protective highway for glucose transport from perivascular astrocytic feet to neuronal synapses.9,39 Using ER-targeted glucose Förster resonance energy transfer sensors, they revealed that human fetal astrocytes accumulate glucose in the ER by sequestering G6P from the cytosol via G6PT and hydrolyzing it through G6Pase-β activity (Figures 3B and 3C). Furthermore, they demonstrated that inhibiting G6Pase-β activity through a shRNA sequence delivered by lentiviral particles reduces ER glucose uptake, adenosine triphosphate (ATP) production, and ER Ca2+ uptake.9 As human astrocytes take up glucose through perivascular feet, a region enriched in GLUT1,38 and transport it over several millimeters toward perisynaptic processes,40 Müller et al. introduced two groundbreaking concepts regarding the cerebral G6Pase system: (1) the astrocytic ER could function as a secondary glucose reservoir, separate from glycogen and (2) the ER might provide a secure route for glucose to travel from perivascular feet to perisynaptic processes; this route is shielded from glycolytic enzymes (Figure 3D). Hydrolyzed glucose can be released from the ER lumen into the cytosol, possibly via GLUTs. Upon reaching the cytosol, glucose serves as a local substrate such as ATP or lactate that can be exported to neurons based on energy requirements (Figure 3).9 Although this hypothesis is novel, promising, and suggests that the G6Pase system may modulate neuromodulator synthesis and brain bioenergetics, it presents experimental limitations that should be addressed in the future—for example, through the use of in vivo models. Among the most suitable experimental strategies to study this interaction are astrocyte-specific Cre-LoxP models, which allow targeted modification of genes involved in the G6Pase system (such as G6PT and G6Pase). Similarly, the in vivo use of genetically encoded fluorescent sensors based on fluorescence lifetime imaging, such as iGlucoSnFR, would be a valid experimental strategy to assess cell type–specific changes in glucose concentration in these models.41 Additionally, the iGlucoSnFR sensor,41 when combined with advanced technologies such as holographic tomographic microscopy (in vitro models), could constitute a powerful approach to monitor metabolic dynamics in astrocytes and assess their impact on brain bioenergetics. Furthermore, it is relevant to determine whether glucose released from the ER into the cytosol can regulate key cellular processes, such as extracellular glucose uptake, the modulation of catabolic pathways, and glycogen synthesis in glial cells that express the G6Pase system. To explore this possibility, one could perform live-cell microscopy assays of 2-2-(N-[7-Nitrobenz-2-oxa-1,3-diazol-4-yl]-amino)-2-deoxi-D-glucose (2-NBDG) uptake, metabolic flux analyses using Seahorse technology, and glycogen determinations in G6pase knockdown cultures. These analyses would help clarify the role of the G6Pase system in brain cellular bioenergetics. Although perivascular astrocytes have shed light on the role of the G6Pase system in brain energy dynamics, hypothalamic tanycytes offer a distinct and valuable perspective. Tanycytes, which are located in the third ventricle (3V), are crucial for sensing and regulating systemic energy states. Their specialized characteristics make them ideal models for investigating the G6Pase system’s role in energy regulation, particularly in the hypothalamic control of metabolic homeostasis. The following section delves into the function of the G6Pase system in tanycytes and its broader implications for CNS metabolic regulation. The G6Pase system in hypothalamic tanycytes Tanycytes are specialized ependymoglial cells that line the walls of the hypothalamic 3V and play a crucial role in regulating energy balance.8,42,43,44,45 These glial cells are strategically positioned within the 3V and directly contact the cerebrospinal fluid (CSF) through their apical or proximal regions. Moreover, they form close connections with hypothalamic neuroendocrine neurons through their elongated processes.46,47 Historically, based on their dorsoventral location in the 3V and projection of their basal processes, hypothalamic tanycytes have been classified into four subtypes: α1-, α2-, β1-, and β2-tanycytes.48,49,50 α1-tanycytes extend their processes toward the ventromedial and dorsomedial nuclei, whereas α2-tanycytes project their processes toward the dorsomedial region of the arcuate nucleus (ARC).50 In contrast, β1-tanycytes primarily project their processes toward the proximal region of the ARC, whereas β2-tanycytes occupy the floor of the 3V. Their projections reach the median eminence (ME), where they form tight junctions at the apical surface, creating a barrier between the components of the ME and ventricular CSF.51,52 As technology advances, the classical characterization of tanycytes based on their localization along the dorsoventral axis of the hypothalamus has been complemented by evidence suggesting remarkable cellular heterogeneity. Recent studies have described and hypothesized that tanycytes perform specialized functions in the regulation of energy balance, highlighting their dynamic role within the neuroendocrine system. In line with this notion, transcriptomic analyses have revealed a high degree of heterogeneity in the gene expression of tanycytes.42,53 Interestingly, by combining fluorescence-activated cell sorting (FACS) with single-cell RNA sequencing (scRNA-seq), distinct tanycyte subpopulations have been identified, each exhibiting specific markers while also sharing common genetic profiles.42 Even more strikingly, it has been demonstrated that changes in energy status induce metabolic and functional adaptations in these cells, underscoring their extraordinary plasticity and functional versatility within the hypothalamus.42 These findings emphasize the dynamic role of tanycytes in energy homeostasis and suggest their potential relevance in pathophysiological processes related to metabolism. A growing body of evidence suggests that tanycytes not only exhibit remarkable cellular heterogeneity and metabolic adaptability but also possess unique biochemical properties that may contribute to their role in energy homeostasis. In this context, recent findings indicate that tanycytes share functional similarities with perivascular astrocytes, particularly in their ability to sequester glucose within the ER.8 Recent studies in primary tanycyte cultures have demonstrated that these glial cells express G6PT and the β isoform of G6Pase.8 Furthermore, real-time live cell microscopy studies have revealed that tanycytes can sequester the fluorescent glucose analog 2-NBDG, a process dependent on G6PT and G6Pase-β activities.8 Notably, G6Pase-β is homologous to G6Pase-α, the isoform expressed in hepatocytes. Both isoforms orient their catalytic sites toward the ER lumen and share similar Km values for G6P hydrolysis,54,55 suggesting that tanycytes exhibit similar kinetic properties as hepatocytes with regard to G6P hydrolysis. Regarding in vivo localization, studies on coronal brain sections from 2-month-old mice showed that not all tanycyte populations express the G6Pase system. Immunolocalization analyses have revealed that the G6Pase system is predominantly expressed in the soma and processes of β1- and β2-tanycytes.8 In contrast, G6PT expression is absent in α1- and α2-tanycytes, ependymal cells, and hypothalamic astrocytes.8 Tanycytes-G6Pase system promotes glucose ER storage Extensive research indicates that hypothalamic tanycytes act as glucose-sensing cells, directly detecting glucose from the CSF and inducing responses that mediate the activity of hypothalamic neuroendocrine neurons.56,57,58,59 Supporting this concept, studies have shown that tanycytes can generate two distinct responses based on the glucose concentrations detected by them in the CSF. They are believed to respond to both elevated glucose (hyperglycemia) and depleted glucose levels.8,56,57,60,61 Under hyperglycemia, tanycytes take up glucose from the CSF into their intracellular compartment via GLUT2 or GLUT6,56,57,58,62 which are apically polarized in the cell56,57,62 and have glucose affinity Km values of 17 and 5 mM, respectively.63,64 Once inside the cell, glucose can be phosphorylated to G6P by glucokinase (GK), an enzyme with a glucose affinity constant of approximately 8 mM.61,65 Cytosolic G6P can follow one of two independent pathways. The first involves its entry into the glycolytic pathway, leading to the production of signaling molecules such as ATP or lactate, which contribute to short-term anorexigenic signaling. In ATP-mediated short-term signaling, it has been demonstrated that extracellular glucose stimulation of tanycytes increases intracellular Ca2+ concentration and ATP levels.66,67 Conversely, in lactate-mediated short-term signaling, tanycytes respond to extracellular glucose by releasing lactate to the hypothalamic ARC via monocarboxylate transporter 1 (MCT1) and MCT4, which are predominantly located in the processes of these glial cells.60,68,69 Evidence from murine models and genetic manipulation studies have suggested that tanycyte-derived lactate release is critical for suppressing feeding behavior through the activation of pro-opiomelanocortin (POMC) neurons in the hypothalamic ARC.60 These POMC neurons express MCT269 and are responsive to lactate rather than glucose,60,70 strengthening the hypothesis that tanycyte-to-neuron signaling mediated by lactate is essential for energy regulation. Supporting this hypothesis, it has been demonstrated that the cosilencing of MCT1 and MCT4 in the tanycytes of murine models leads to increased feeding behavior during the dark phase of feeding.71 Therefore, lactate release from tanycytes to POMC neurons can trigger the cessation of feeding when blood glucose concentrations rise above 5 mM. As an alternative pathway, cytosolic G6P can follow a route that is 500–3,700 times slower than lactate production.31,72 In this route, G6P is transported into the ER of tanycytes via G6PT.8 Here, the ER acts as a secondary glucose reservoir, distinct from the glycogen stores already present in these glial cells73,74 (Figure 4). Supporting this mechanism, real-time live cell microscopy studies have shown that tanycytes can retain the 2-NBDG probe in the ER for over 30 min. This process is disrupted when tanycytes are treated with the G6PT inhibitor chlorogenic acid or the G6Pase inhibitor Thielavin A.8 This leads to a critical question: why do tanycytes store glucose in the ER during hyperglycemia? One possibility is that, under hyperglycemic conditions, tanycytes use the ER to transport glucose in a protected manner to specific sites where this substrate is required. In this way, tanycytes could release glucose into the cytosol, which may eventually be metabolized to lactate. Although this possibility has not been tested, one way to analyze it would be by using primary cultures of control tanycytes and those incubated with the pharmacological inhibitor of G6Pase, Thielavin A. Subsequently, upon increases in extracellular glucose concentration, lactate release into the culture medium could be evaluated in both cultures. However, along with this possibility emerging evidence suggests that tanycytes subsequently utilize these ER glucose reserves to supply nutrients to ARC neurons when CSF glucose concentrations drop.8 The basis of this glucose shuttle hypothesis will be discussed in the following section. G6Pase system in hypothalamic tanycytes Under hypoglycemia, tanycytes increase the expression of G6Pase-β, enhancing the hydrolysis of G6P in the ER. The resulting free glucose is transported from the ER into the cytosol and subsequently released into the extracellular space via GLUT1, which is predominantly located in the processes of tanycytes. The glucose is then taken up by NPY neurons through GLUTs, leading to neuronal activation and initiating feeding behavior in response to hypoglycemia. GLUT1, glucose transporter 1; GLUT2, glucose transporter 2; GLUT6, glucose transporter 6; GK, glucokinase; G6PT, glucose-6-phosphate transporter; G6Pase-β, glucose-6-phosphatase-β; ER, endoplasmic reticulum; G6P, glucose-6-phosphate; NPY, neuropeptide Y. Can tanycytes release nutrients during hypoglycemia? As discussed in the previous chapter, tanycytes can release anorexigenic signals such as ATP or lactate in response to hyperglycemia.60,66,67 However, the full spectrum of signals released by tanycytes remains largely uncharacterized. In particular, the signals they release under hypoglycemic conditions have been poorly described and much remains to be understood about their role in energy balance and metabolic adaptation. However, recent evidence suggests that tanycytes undergo spatial reconfiguration during fasting and exhibit metabolic adaptations in response to decreased glucose availability.42 In adult mice, fasting has been shown to suppress protein processing while enhancing the mRNA processing of genes involved in lipid and cholesterol metabolism.42 Additionally, fasting tanycytes may release β-hydroxybutyrate and exhibit reduced intracellular ATP synthesis, potentially leading to diminished ATP release and a subsequent decrease in extracellular adenosine conversion.42,75 Collectively, these findings highlight the remarkable functional and metabolic plasticity of tanycytes in response to fasting, underscoring their role in preserving cerebral homeostasis under conditions of energy imbalance. Moreover, compelling evidence also suggests that tanycytes may mobilize glucose reserves from the ER in response to hypoglycemia.8 In line with this evidence, it is proposed that glucose release from the ER occurs rapidly, unlike glycogenolysis, which can take minutes or even hours for glucose release.76 This raises a key question: how do tanycytes release glucose? Remarkably, studies in primary tanycyte cultures incubated for 2 h without glucose have shown that these cells can release glucose into the extracellular medium in vitro.8 Further evidence indicates that this glucose release depends on G6P hydrolysis, a reaction mediated by G6Pase-β (Figure 4).8 Collectively, these findings suggest that tanycytes rely on the G6Pase system to hydrolyze G6P within the ER and subsequently release glucose into the extracellular medium. An important aspect to address in the context of glucose export from the ER in tanycytes is the identification of potential intracellular and/or extracellular mechanisms that may modulate this process during hypoglycemia. Interestingly, at the intracellular level, studies have suggested that the expression of the enzyme G6Pase is required to stimulate glucose release from the ER.77 In this context, it has been demonstrated that mutations in the gene encoding the G6Pase enzyme lead to severe hypoglycemia and glycogen accumulation in the liver.77 Additionally, at the systemic level, it has been proposed that glucagon could act as a possible extracellular signal that stimulates glucose release during fasting.78 In this regard, it has been suggested that this hormone can activate a Smad3-mediated signaling pathway, which acts synergistically with transforming growth factor (TGF-β1) signaling to increase the expression of the G6Pase-β gene and thereby promote glucose release from the liver.78 Given that tanycytes express multiple receptors for peripheral hormones,45,79,80 it is tempting to hypothesize that glucose export from the ER in tanycytes could eventually be modulated by peripheral signals released during hypoglycemia. However, this hypothesis still faces major technological limitations that hinder the in vivo evaluation of such a complex mechanism. Glucose can be exported from the ER lumen into the cytosol and subsequently into the extracellular medium, and tanycytes might eventually rely on GLUTs to facilitate this process. Supporting this, studies using primary tanycyte cultures transduced with baculovirus ER-RFP have revealed that tanycytes express GLUT1, GLUT2, and GLUT6 at the ER membrane.8 Notably, live-cell microscopy studies suggest that the combined activity of GLUT1 and GLUT2, but not GLUT6, may be important for glucose release from the ER.8 This finding raises an important question: how is glucose released in an in vivo system? In situ immunolocalization studies have shown that mouse tanycytes exhibit a polarized and strategic distribution of GLUTs.8,56,57,59,62,81 As previously discussed, GLUT2 and GLUT6 are predominantly localized on the apical surface, allowing direct contact with the CSF.56,57,62 Interestingly, β1-tanycytes—the primary cell population expressing the G6Pase system display high levels of GLUT1 in their processes that interact with neurons in the hypothalamic parenchyma.59,81 Considering that glucose concentrations in the hypothalamic parenchyma remain relatively stable during hypo- or hyper-glycemia,76 it is unlikely that GLUT1 is localized in tanycyte processes to import glucose from the hypothalamic parenchyma. Instead, it is tempting to speculate that GLUT1 in these processes may facilitate glucose release. Supporting this hypothesis, studies in primary mouse astrocyte cultures have suggested that GLUT1 may act as a bidirectional GLUT.82 Moreover, recent findings have shown that a decline in peripheral glucose concentrations increases the permeability of 2-NBDG in the ARC, a process dependent on GLUT1 expression in tanycytes.59,81 These findings suggest that tanycytes release glucose into the hypothalamic parenchyma via GLUT1 in response to hypoglycemia (Figure 4).81 The β1-tanycyte population, which coexpresses G6PT and GLUT1,8,59,81 occupies a critical position in the hypothalamus, with their processes closely interacting with neuroendocrine neurons in the ARC.8,59,81 Owing to this strategic positioning, it has been proposed that β1-tanycytes can release glucose pulses to ARC neurons, thereby regulating their activity and modulating overall energy balance. The evidence supporting this hypothesis will be detailed in the following section. The G6Pase system controls brain homeostasis The G6Pase system has been scarcely studied in the brain, and its role in regulating cerebral energy homeostasis remains a largely—almost entirely—an unexplored field. Nevertheless, emerging evidence provides clues as to how this system, associated with endoplasmic glucose storage, might contribute to the regulation of brain energy balance. As previously noted, G6Pase system activity in astrocytes appears to be crucial for meeting the energy demands of nervous tissue, particularly those neuronal populations without direct access to external glucose sources.9,31,39 These neurons rely on metabolic intermediates capable of detecting and responding to fluctuations in the brain’s energetic state. Interestingly, recent research has tentatively proposed new hypotheses regarding additional functions of G6Pase, suggesting that it might act as a central metabolic repair enzyme.33 Specifically, studies in neutrophil granulocytes have shown that the G6Pase-β isoform is capable of removing, via dephosphorylation, the compound 1,5-anhydroglucitol-6-phosphate (1,5-AHG6P).83 This metabolite is formed through the phosphorylation of 1,5-anhydroglucitol (1,5-AHG), a dietary derivative and glucose analog that inhibits hexokinase activity, thereby interfering with glycolysis and cellular energy production.84,85 Some patients with G6Pase-β deficiency have shown mild learning disabilities and cognitive difficulties, leading to the hypothesis that the absence of this enzyme may result in toxic accumulation of 1,5-AHG6P.33 This accumulation could disrupt cellular metabolism in the CNS, thereby affecting cognitive processes.33 However, the relationship between this metabolic disturbance and brain function is not yet fully understood, and further studies are needed to determine its true neurological impact. On the other hand, the function of the G6Pase system in the hypothalamus has also been evaluated, suggesting its influence on energy balance control and opening new lines of research into its potential role in central metabolic regulation and its connection to neuroendocrine functions. In the hypothalamus, expression of the G6Pase system has been detected in both astrocytes and tanycytes.8,86 Recently, it has been proposed that astrocytes located in the ventromedial nucleus (VMN) region express the G6Pase-β.86 Interestingly, the silencing of G6Pase-β in the VMN attenuated the secretion patterns of corticosterone and growth hormone during hypoglycemia, while enhancing glucagon secretion.86 These results suggest that G6Pase-β activity in the VMN may play a role in regulating counter-regulatory responses to hypoglycemia.86 In tanycytes, the expression of the G6Pase system has been reported in the population of β1 tanycytes, which are in direct contact with neurons of the ARC.8 To investigate whether tanycytes can modulate the activity of ARC neurons and regulate energy balance, researchers specifically silenced G6pt in mouse tanycytes using an adeno-associated virus expressing shRNA targeting G6pt mRNA.8 Interestingly, c-Fos analysis revealed that silencing of G6pt in tanycytes led to a reduction in the number of c-Fos-positive cells in the ARC, which was observed only after 24 h of food deprivation.8 These findings suggest that G6PT-positive tanycytes regulate ARC neuronal activity exclusively during fasting, not during feeding. Fasting activates neuropeptide Y (NPY) neurons in the ARC,87,88,89 which are central to integrating metabolic signals that regulate feeding behavior and energy expenditure.90 Notably, in vivo studies have shown that the silencing of G6pt in tanycytes reduces NPY expression in response to fasting.8 This reduction was observed only in orexigenic NPY neurons and not in anorexigenic POMC neurons, whose activity is primarily mediated by lactate.60,75,91 This distinction can be explained by the nature of NPY neurons. As demonstrated by Fioramonti in 2007, NPY neurons are glucose-inhibited (GI) neurons, indicating that their activity is suppressed by glucose.92 Single-cell analysis of rat hypothalamic slices revealed that 40% of NPY neurons are GI neurons.93 These neurons express GLUT2 and the enzyme GK, responding to hypoglycemia through glucose metabolism.94,95,96 Furthermore, electrophysiological studies have shown that NPY neuron activation occurs within a narrow glucose concentration range of 0.1–2.5 mM.97 As NPY neurons play a critical role in responding to hypoglycemia, glucose concentrations in the hypothalamic parenchyma must be tightly regulated within this range, activating NPY neurons to promote hyperphagia during fasting.8 Importantly, NPY neurons are located in hypothalamic regions that are not directly exposed to the CSF, where glucose concentrations fluctuate with blood glucose levels.98 Based on this finding, a glucose transfer mechanism was proposed from the CSF to the ARC during hypoglycemia, ensuring that glucose concentrations remain between 0.1 and 2.5 mM.8 Such a glucose transfer mechanism during hypoglycemia could prevent neuroglycopenia (glucose deprivation that impairs neuronal function)98 and maintain optimal glucose concentrations to activate NPY neurons, thereby promoting food intake.8 In this context, G6PT- and GLUT1-positive tanycytes may transfer glucose from their ER reservoirs to NPY neurons. Furthermore, metabolic phenotypic analysis of G6PT knockdown mice strongly supports this hypothesis. Specifically, silencing of G6PT in tanycytes, but not in other hypothalamic glial cells, resulted in substantial body weight reduction in mice. This weight loss was linked to decreased adiposity in epididymal and perirenal white adipose tissues, with no effect on lean mass.8 Additionally, feeding behavior experiments demonstrated that silencing of G6PT in tanycytes reduced adiposity and body weight by decreasing total food intake during fasting. These G6PT knockdown mice displayed altered satiety, showing a diminished response to prolonged fasting and consuming less food than control mice under similar physiological conditions. Collectively, these findings suggest that glucose pulses released from tanycytes to NPY neurons are crucial for their activation, subsequently driving food intake during fasting.8 Nevertheless, considering the high heterogeneity of hypothalamic tanycytes,53 it is important to analyze in the G6PT knockdown model whether other cellular or physiological alterations may have contributed to the development of the anorexigenic metabolic phenotype characteristic of this in vivo model. For example, it would be pertinent to evaluate whether G6pt silencing in tanycytes could lead to changes in ME permeability, lactate signaling under hyperglycemic conditions, circadian cycle regulation, among other factors. Furthermore, it is important to emphasize that the physiological studies conducted in G6pt knockdown mice were performed exclusively in males. Since experimental evidence suggests that hypothalamic tanycytes exhibit marked differences between males and females,99,100 and that estrogen at the peripheral level can decrease the expression levels of the liver G6Pase enzyme,101 it is relevant to assess whether the G6Pase system plays a different role in females. Recently, elegant evidence presented by Fernandois and colleagues suggested that female tanycytes express the estrogen receptor α (ERα), which enables them to detect estradiol.100 In this context, estradiol detection in tanycytes may stimulate NPY-dependent anorexigenic signaling.100 Therefore, in light of this scenario, it is tempting to hypothesize that the G6Pase system could play a different role in females and may eventually participate through an ERα-mediated estrogenic signaling pathway in tanycytes. However, as this evidence is still emerging, further research is necessary to validate and expand upon this promising hypothesis. Concluding remarks and future perspectives Historically, the G6Pase system has been known for its role in facilitating glucose release in peripheral tissues. However, in 2018, emerging hypotheses expanded its functional significance to the CNS. Within the brain, the G6Pase systems in astrocytes and hypothalamic tanycytes have been identified as a key regulator of brain homeostasis. In astrocytes, the G6Pase system is associated with the regulation of neuronal activity, cognitive processes and the counter-regulatory response to hypoglycemia. Conversely, in hypothalamic tanycytes, the G6Pase system is predominantly linked to the control of appetite, regulation of fat stores, and maintenance of body weight. These discoveries not only redefine the functional landscape of the G6Pase system in the brain but also position astrocytes and tanycytes as a novel and promising therapeutic target for metabolic disorders. By harnessing hypothalamic glial cells’ unique capacity to regulate glucose storage, novel interventions could be developed to restore energy homeostasis and manage conditions such as obesity and diabetes. Acknowledgments This work was supported by grants from the Agencia Nacional de Investigación y Desarrollo-ANID: “Fondecyt de iniciación” N°11240089 (to M.J.B.), “Fondecyt regular” N°1240486 (to K.S.), and “Fondecyt regular” N° 1221147 (to F.N.). Additionally, this work was supported by Vicerrectoría de Investigación y Doctorados de la Universidad San Sebastián – Fondo USS-FIN-25-FATE-01 (to M.J.B.). Author contributions M.J.B., F.N., and K.S. investigated and analyzed the data. M.J.B. wrote the manuscript and designed the illustrations. F.N. and K.S. reviewed the manuscript. Declaration of interests The authors declare no competing interests. Contributor Information María José Barahona, Email: maria.barahona@uss.cl. Francisco Nualart, Email: fnualart@udec.cl. References